TICKER: $XBI XBI will be testing daily resistance $97.00. The nasdaq biotech $IBB already broke its daily resistance so can XBI follow along? Again, dividend distribution was this week and it has an impact on the price. However, I would still be caution because the weeky RSI is pretty extended. RSI is @ 71ish and historic pullback RSI level is around...
Ascending Wedge Reversal. Volume is there and ready to go. Generic opioid manufacturers have been beaten down recently over fear of a copious monetary fine, but MNK has an established diverse profile. Do NOT miss this stock when it runs. Break above $4.15 and were off Long Term Target: $12.90
www.va.se finansavisen.no PCI Biotech OSL:PCIB is a biopharmaceutical company focusing on development and commercialisation of novel therapeutic solutions for improved treatment of cancer patients through its innovative photochemical internalisation (PCI) technology platform. PCI induces triggered endosomal release that can be used to unlock the...
BerGenBio OSL:BGBIO is a norwegian clinical-stage biopharmaceutical company focused on developing transformative drugs targeting AXL as a potential cornerstone of therapy for aggressive diseases, including immune-evasive, therapy resistant cancers. The stock is currently in a short term uptrend that could provide a new test of important resistance, where a...
Ticker: $XBI The biotech sector have been on absolute fire these couple of weeks. Check out the weekly chart with higher lows every candlestick. The daily chart is getting toppy with somewhat of a double top at $96.61. Break $94.08 this upcoming week and that will signal weekly consolidation. I will be scouting for a bearish play with LABD this upcoming...
EYPT chart is building up for another run. Potential catalyst before year end with an sNDA for Short Duration Yutiq. accumulation has been slow and steady indicating EYPT oversold conditions. Technical's: weekly chart --> Harmonic Gartley (bounced off significant support level) and been in uptrend since. Symmetrical Triangle/ Breakout setup has been known...
buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it
Traded in a 7 month range. Company plans on making 30million for the fiscal year 2021. 100mill marketcap so IT IS considered undervalued. TP at 2.40. TP 2 3.50. SL 1.60.
Biotech buyouts have been very strong, especially with Gene therapy stocks as of late. Bounced off Lower end of channel Gartley pattern bounced off 1.618 fib extension along with important reversal leg of Elliott Wave Theory. if price holds inside the lower end of the channel there is a potential move back up and test the gap. looking for nice $0.40+ swing...
Ticker: $XBI XBI needs to break 94.95 to break out hard. If we reject and form a 4 hour lower high compared to 94.95, WATCH OUT FOR THE 4H INVERSE HEAD AND SHOULDERS with support for 92.97 and 91.68!!! Also watch for market correlation. If market is strong and hits ALL TIME HIGH, XBI could be in a great position to go long.
Cassava Sciences (SAVA) just got some positive clinical trial data on their Alzheimer’s drug. The result caused one analyst firm to upgrade SAVA’s price target from $3.00 per share to $6.00 per share. SAVA’s got a 9.4/10 analyst summary score, with most analysts rating the stock a “buy.” I entered SAVA Friday morning at $2.16 per share. It’s already up almost 100%...
Speculative long on PLX. Accelerated path to approval from FDA. From TA standpoint - charts tried to make a diamond a couple of times, but failed. Will third time be successful to push higher? Opened for 2k shares at .24
www.tradingview.com
This is just garbage. Sitting here a bubbly parabolic ATH's. This is the #1 short on the planet right now. Overbought on the fucking weekly now in both RSi and MFI. The top is in.